NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000021309

Registered date:03/03/2016

Assessment of the safety of nicotinamide mononucleotide (NMN) in healthy subjects; phase I study. The clinical trial to evaluate metabolic-syndrome-related parameters to develop NMN as Foods with Function Claims.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedhealthy subjects
Date of first enrollment2016/03/09
Target sample size10
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)the single intake of NMN.

Outcome(s)

Primary Outcomethe safety of NMN (physical and laboratory examinations).
Secondary Outcomethe kinetics of NMN.

Key inclusion & exclusion criteria

Age minimum40years-old
Age maximum60years-old
GenderMale
Include criteria
Exclude criteria1 the subjects with a previous history of diseases. 2 the subjects with malignant neoplasms. 3 the subjects with serious infections. 4 the subjects with psychiatric disorders. 5 the subjects with ophthalmic disorder. 6 the subjects with allergic disorders. 7 the subjects who are regarded as inadequate by the investigator.

Related Information

Contact

public contact
Name Junichiro Irie
Address 35 Shinanomachi, Shinjuku, Tokyo, JAPAN Japan 1608582
Telephone 03-5363-3797
E-mail j-irie@z8.keio.jp
Affiliation Keio University School of Medicine Division of Endocrinology, Metabolism and Nephrology
scientific contact
Name Hiroshi Itoh
Address 35 Shinanomachi, Shinjuku, Tokyo, JAPAN Japan
Telephone 03-5363-3797
E-mail hiito@z8.keio.jp
Affiliation Keio University School of Medicine Division of Endocrinology, Metabolism and Nephrology